This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Time to Buy & Hold Tesla (TSLA) Stock?
by Benjamin Rains
Shares of Tesla (TSLA) popped nearly 3% Friday morning after Jefferies upgraded the electric vehicle giant's stock. Looking ahead, Tesla appears poised for massive growth as it becomes a more profitable company on the back of Model 3 expansion.
The Zacks Analyst Blog Highlights: Apple, Amazon, Facebook, eBay and Etsy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, Amazon, Facebook, eBay and Etsy
Apple Roundup: Music, App Store Monopoly, Analyst Opinion
by Sejuti Banerjea
Apple (AAPL) is deepening its relationship with Amazon through a music streaming alliance, its app store monopoly case has reached the Supreme Court and analysts are weighing in on iPhone demand.
Most Interesting New ETFs
by Neena Mishra
We highlight a couple of interesting ETFs that made their debut recently.
Facebook Acquires Rights to Three Classic Shows for Watch
by Zacks Equity Research
Reportedly, Facebook (FB) acquires streaming rights for three classic shows from Twenty-First Century Fox for its video platform, Watch.
Facebook (FB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Facebook (FB) closed the most recent trading day at $141.09, moving +0.34% from the previous trading session.
Pro Leagues Embrace Sports Betting & the Basketball Shoe Market Expands
by Benjamin Rains
On this episode of the Full-Court Finance podcast, Associate Stock Strategist Ben Rains dives into the latest sports betting news as MLB joins the fun. He then breaks down another well-known company's jump into the business of basketball.
What's in Store for Verint Systems (VRNT) in Q3 Earnings?
by Zacks Equity Research
Verint Systems' (VRNT) third-quarter fiscal 2019 earnings are likely to benefit from demand for advanced analytical solutions and data protection software.
Healthcare Takes Wall Street Lead: 4 Picks
by Tirthankar Chakraborty
Continuous innovation and research in the field of biotechnology and an increasingly aged population in the United States are helping whet appetite for healthcare shares.
Better Long-Term Buy: Amazon (AMZN) vs. Microsoft (MSFT) Stock
by Benjamin Rains
Both AMZN and MSFT are up big over the last year and the companies are headed in the right direction. So which stock looks like a better long-term buy at the moment?